Hacker News new | ask | show | jobs
by InSteady 1019 days ago
Really hard to get proper funding for LDN. It is an already incredibly cheap drug in a minute dose... this treatment is not exciting to anyone except patients and a few passionate researchers.

Lots of studies showing "interesting results, needs more investigation" but high quality studies are very slow to come...